Pascal Mallefet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pascal Mallefet has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Donald Shelton
Department of Preclinical Development, Novartis Consumer Health, Nyon, Switzerland
1 shared publication - Gilbert Ponard
Department of Preclinical Development, Novartis Consumer Health, Nyon, Switzerland
1 shared publication - Marlene Bader
Department of Preclinical Development, Novartis Consumer Health, Nyon, Switzerland
1 shared publication - Martina Schaffrik
Department of Medical Affairs, Novartis Consumer Health, Munich, Germany
1 shared publication - Nathalie Hasler-Nguyen
Department of Preclinical Development, Novartis Consumer Health, Rte Etraz, Nyon, Switzerland
1 shared publication
Latest Publications
- Open Access
- 2 April 2009
- Published by Springer Nature in BMC Dermatology
- Vol. 9 (1) , 3
Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus, approximately 40% suffer from recurrent recurrent infections. This study evaluates the in vitro skin permeation and penetration of penciclovir and acyclovir from commercialized creams for the treatment of herpes labialis (cold sores), using non viable excised human abdominal skin samples, which were exposed to 5 mg/cm2 of acyclovir 5% cream or penciclovir 1% cream.
- 2 April 2009
- Published by Springer Nature in BMC Dermatology
- Vol. 9 (1) , 3
Open AccessEvaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus, approximately 40% suffer from recurrent recurrent infections. This study evaluates the in vitro skin permeation and penetration of penciclovir and acyclovir from commercialized creams for the treatment of herpes labialis (cold sores), using non viable excised human abdominal skin samples, which were exposed to 5 mg/cm2 of acyclovir 5% cream or penciclovir 1% cream.